The percentage of Egr2 positive TILs varied greatly in different tumours with ~ 30% in TILs from colorectal cancer, ~ 15% in those from liver cancer and ~ 9% in TILs from lung cancer (Fig. 1A, Supplementary Table 1). This evidence concerns the gene EGR2 and liver cancer.